HIGHLIGHTS
- who: Umar Wazir et al. from the The London Breast Institute, Princess Grace Hospital, London W U NY, UK have published the research work: Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review, in the Journal: Cancers 2022, 14, x FOR PEER REVIEW of /2022/
- what: The aim of this systematic review was to assess the eradication rate of DCIS by NST given for invasive breast cancer. For the purposes of this systematic review, MEDLINE and The data presented in this study demonstrate that 40% of DCIS can be . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.